Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91,844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder.
Zhao Q, Fu B, Lyu N, Xu X, Huang G, Tan Y, Xu X, Zhang X, Wang X, Wang Z, Li K, Hu Z, Li H, He H, Li S, Zhao J, He R, Guo H, Li Y, Li L, Yang C, Zou S, Wei B, Wang W, Chen C, Lu Z, He S, Wang Q, Zhao J, Pan X, Pan Z, Li J, Wang G. Zhao Q, et al. Among authors: li s, li y, li j, li h, li k, li l. J Affect Disord. 2023 May 15;329:72-80. doi: 10.1016/j.jad.2023.02.067. Epub 2023 Feb 20. J Affect Disord. 2023. PMID: 36813043 Free article. Clinical Trial.
Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, Ye M, Huang J, Zhu S, Wang G, Zhang Q, Zheng H, Zhang L, Wang B, Zhou J, Zhao JP. Fang M, et al. Among authors: li y, li lh. Int Clin Psychopharmacol. 2012 Mar;27(2):107-13. doi: 10.1097/YIC.0b013e32834fc431. Int Clin Psychopharmacol. 2012. PMID: 22233697 Clinical Trial.
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.
Li H, Yao C, Shi J, Yang F, Qi S, Wang L, Zhang H, Li J, Wang C, Wang C, Liu C, Li L, Wang Q, Li K, Luo X, Gu N. Li H, et al. Among authors: li j, li k, li l. J Psychiatr Res. 2015 Oct;69:102-9. doi: 10.1016/j.jpsychires.2015.07.015. Epub 2015 Jul 23. J Psychiatr Res. 2015. PMID: 26343601 Free article. Clinical Trial.
Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia.
Feng Y, Shi J, Wang L, Zhang X, Tan Y, Zhao J, Ning Y, Xie S, Liu X, Liu Q, Li K, Wang X, Li L, Xu X, Deng W, Luo X, Wang G. Feng Y, et al. Among authors: li k, li l. Psychiatry Clin Neurosci. 2020 Jun;74(6):336-343. doi: 10.1111/pcn.12965. Epub 2020 Jan 8. Psychiatry Clin Neurosci. 2020. PMID: 31823444 Free PMC article. Clinical Trial.
Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial.
Mi W, Yang F, Li H, Xu X, Li L, Tan Q, Wang G, Zhang K, Tian F, Luo J, Xia J, Yuan K, Lu L, Deng J, Tian J, Zhang H. Mi W, et al. Among authors: li h, li l. Int J Neuropsychopharmacol. 2022 Mar 17;25(3):252-260. doi: 10.1093/ijnp/pyab074. Int J Neuropsychopharmacol. 2022. PMID: 34747448 Free PMC article. Clinical Trial.
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder.
Mi W, Di X, Wang Y, Li H, Xu X, Li L, Wang H, Wang G, Zhang K, Tian F, Luo J, Yang C, Zhou Y, Xie S, Zhong H, Wu B, Yang D, Chen Z, Li Y, Chen J, Lv S, Yi Q, Jiang Z, Tian J, Zhang H. Mi W, et al. Among authors: li y, li h, li l. Transl Psychiatry. 2023 May 10;13(1):163. doi: 10.1038/s41398-023-02435-0. Transl Psychiatry. 2023. PMID: 37164957 Free PMC article. Clinical Trial.
91,844 results
You have reached the last available page of results. Please see the User Guide for more information.